A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City
Por um escritor misterioso
Descrição
Post-acute neurological consequences of COVID-19: an unequal burden
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
/cloudfront-us-east-2.images.arcpublishing.com/reuters/4DO6BNFFH5NS5EDGC7AHTISQNU.jpg)
Nerve damage may explain some cases of long COVID -U.S. study
Acute Ischemic Stroke and COVID-19
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
CTN, Free Full-Text
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC study - eBioMedicine
Early Convalescent Plasma for High-Risk Outpatients with Covid-19
Real-time pandemic surveillance using hospital admissions and mobility data
Covid May Cause Changes in the Brain, New Study Finds - The New York Times
Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms
Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021
de
por adulto (o preço varia de acordo com o tamanho do grupo)
